Feed LNSR
LN

LENSAR, Inc.

LNSR · NASDAQ

$7.25 -0.68% (-$0.05)
1M -21.45%
Market Cap $89.0M
P/E Ratio 2.57x
Div. Yield -
ROE -
Piotroski F-Score Moderate
5/9
Valuation
87 /100
Cheap
P/S 1.48x
P/E 2.57x
P/B 5.97x
Growth
100 /100
Growing
Rev. growth 18.23%
Book val. growth N/A
EPS growth N/A
Profitability
39 /100
Moderate
Op. margin 13.48%
Gross margin 47.96%
FCF margin 12.16%
Quality
37 /100
Average
Asset turnover 0.87x
ROIC 22.01%
ROA 49.88%
Debt
100 /100
Low
Net debt/EBITDA -0.31x
Debt/Equity 0.16x
Current ratio 2.39x
Stability
55 /100
Moderate
EPS volatility 73.22%
Beta 0.97x
Profitable years 0

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre LNSR
Online

Despre companie

LENSAR, Inc. (LSR) is an American company focused on the development and manufacturing of advanced technologies for surgical ophthalmology. With a product portfolio including innovative surgical systems like the LENSAR® Laser System, LENSAR provides state-of-the-art solutions for cataract procedures. Their technology combines advanced robotics, 3D imaging, and laser energy, enabling precise and personalized surgical interventions for patients. LENSAR, Inc. also emphasizes continuous development and innovation in the field of ophthalmic surgery. Shares of LENSAR, Inc. (LSR) could be suitable for investors seeking opportunities in the healthcare technology sector with a focus on ophthalmic surgery and innovative technologies.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Medical - Devices

CEO

Nicholas T. Curtis

Employees

150

Headquarters

Orlando

Evenimente viitoare

12 NOV.

Earnings

Upcoming earnings report

50d

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.